Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-18.36%
operating margin TTM
-6.19%
revenue TTM
1.10 Billion
revenue per share TTM
20.23$
valuation ratios | |
|---|---|
| pe ratio | -1.37 |
| peg ratio | -0.15 |
| price to book ratio | 0.54 |
| price to sales ratio | 0.26 |
| enterprise value multiple | -7.68 |
| price fair value | 0.54 |
profitability ratios | |
|---|---|
| gross profit margin | 30.86% |
| operating profit margin | -6.19% |
| pretax profit margin | -13.76% |
| net profit margin | -18.36% |
| return on assets | -13.72% |
| return on equity | -37.35% |
| return on capital employed | -5.24% |
liquidity ratio | |
|---|---|
| current ratio | 3.69 |
| quick ratio | 1.77 |
| cash ratio | 0.61 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 158.50 |
| operating cycle | 212.82 |
| days of payables outstanding | 30.97 |
| cash conversion cycle | 181.85 |
| receivables turnover | 6.72 |
| payables turnover | 11.79 |
| inventory turnover | 2.30 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.48 |
| debt equity ratio | 1.37 |
| long term debt to capitalization | 0.58 |
| total debt to capitalization | 0.58 |
| interest coverage | -0.91 |
| cash flow to debt ratio | 0.09 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.68 |
| cash per share | 1.88 |
| operating cash flow per share | 1.11 |
| free cash flow operating cash flow ratio | 0.61 |
| cash flow coverage ratios | 0.09 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 2.56 |
Frequently Asked Questions
When was the last time Emergent BioSolutions Inc. (NYSE:EBS) reported earnings?
Emergent BioSolutions Inc. (EBS) published its most recent earnings results on 07-11-2024.
What is Emergent BioSolutions Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Emergent BioSolutions Inc. (NYSE:EBS)'s trailing twelve months ROE is -37.35%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Emergent BioSolutions Inc. (EBS) currently has a ROA of -13.72%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did EBS's net profit margin stand at?
EBS reported a profit margin of -18.36% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is EBS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.69 in the most recent quarter. The quick ratio stood at 1.77, with a Debt/Eq ratio of 1.37.